000 01094 a2200385 4500
005 20250512082124.0
264 0 _c19850306
008 198503s 0 0 eng d
022 _a0361-5960
040 _aNLM
_beng
_cNLM
100 1 _aSimmonds, M A
245 0 0 _aPhase II study of mitolactol in metastatic malignant melanoma.
_h[electronic resource]
260 _bCancer treatment reports
_cJan 1985
300 _a65-7 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aBone Marrow
_xdrug effects
650 0 4 _aDrug Evaluation
650 0 4 _aFemale
650 0 4 _aHemoglobins
_xanalysis
650 0 4 _aHumans
650 0 4 _aLeukocyte Count
650 0 4 _aMale
650 0 4 _aMelanoma
_xdrug therapy
650 0 4 _aMiddle Aged
650 0 4 _aMitolactol
_xadverse effects
650 0 4 _aNeoplasm Metastasis
650 0 4 _aPlatelet Count
700 1 _aLipton, A
700 1 _aHarvey, H A
700 1 _aEllison, N
700 1 _aWhite, D S
773 0 _tCancer treatment reports
_gvol. 69
_gno. 1
_gp. 65-7
999 _c3972946
_d3972946